Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Increased L-selectin on monocytes is linked to the autoantibody profile in systemic sclerosis
ID
Brezovec, Neža
(
Author
),
ID
Perdan-Pirkmajer, Katja
(
Author
),
ID
Kuret, Tadeja
(
Author
),
ID
Burja, Blaž
(
Author
),
ID
Sodin-Šemrl, Snežna
(
Author
),
ID
Čučnik, Saša
(
Author
),
ID
Lakota, Katja
(
Author
)
PDF - Presentation file,
Download
(1,93 MB)
MD5: 2F0E3261DAE12E548D82FF474D2DFE41
URL - Source URL, Visit
https://www.mdpi.com/1422-0067/23/4/2233
Image galllery
Abstract
Monocytes are known to be implicated in the pathogenesis of systemic sclerosis (SSc), as they exert prominent migratory, adhesive, and chemotactic properties. The aim of our study was to characterize the surface expression of adhesion/chemotactic molecules (CD62L, CD11b, CCR2, CCR5) on the SSc monocytes and determine correlations with the clinical presentation of SSc. We included 38 SSc patients and 36 healthy age-and sex-matched controls. Isolated monocytes, as well as in vitro serum-treated monocytes, were analyzed by flow cytometry; additionally, soluble CD62L was measured in serum. We found increased soluble CD62L in the SSc serum samples and increased CD62L on the surface of the SSc monocytes in the in the same set of patients. Among samples with determined SSc-specific autoantibodies, the surface CD62L was the lowest in patients positive for anti-PM/Scl autoantibodies and the highest in patients with anti-topoisomerase I autoantibodies (ATA). The treatment of isolated healthy monocytes with ATA-positive SSc serum resulted in increased surface CD62L expression. Moreover, surface CCR5 was reduced on the monocytes from SSc patients with interstitial lung disease but also, along with CCR2, negatively correlated with the use of analgesics/anti-inflammatory drugs and immunosuppressants. In conclusion, increased CD62L on SSc monocytes, particularly in ATA-positive patients, provides new insights into the pathogenesis of SSc and suggests CD62L as a potential therapeutic target.
Language:
English
Keywords:
systemic sclerosis
,
monocytes
,
autoantibodies
,
adhesion
,
chemotaxis
,
CD62L
,
CCR2
,
CCR5
,
CD11b
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
15 str.
Numbering:
Vol. 23, iss. 4, art. 2233
PID:
20.500.12556/RUL-137285
UDC:
61
ISSN on article:
1422-0067
DOI:
10.3390/ijms23042233
COBISS.SI-ID:
98089987
Publication date in RUL:
09.06.2022
Views:
845
Downloads:
123
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
International journal of molecular sciences
Shortened title:
Int. j. mol. sci.
Publisher:
MDPI
ISSN:
1422-0067
COBISS.SI-ID:
2779162
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
17.02.2022
Secondary language
Language:
Slovenian
Keywords:
sistemska skleroza
,
monociti
,
avtoprotitelesa
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
Z3-9261
Name:
Raziskovanje mehanizmov, ki povzročajo fibrozo pri sistemski sklerozi
Funder:
ARRS - Slovenian Research Agency
Project number:
J7-8276
Name:
Vpliv protirevmatičnih zdravil na inzulinsko rezistenco in energijsko presnovo v skeletni mišici
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0314
Name:
Sistemske avtoimunske bolezni
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back